A New Study Targets Genetic Risk For Mental Illness
A study in mice by Joseph Gogos, PhD, shows potential for gene-targeting therapy in treating schizophrenia.
A study in mice by Joseph Gogos, PhD, shows potential for gene-targeting therapy in treating schizophrenia.
The evolutionarily ancient part of the brain that controls breathing and heart rate also regulates the immune system — a discovery about the brain-body axis made by the Zuker lab.
Ishmail Abdus-Saboor, PhD, talks about the importance of collaboration, humanity and diversity in science.
New research by Anthony Fitzpatrick, PhD, and others shows that tau, once seen as a secondary player, has now taken a leading role in combating neurodegenerative illnesses.
An international research team headed by Joseph Gogos, MD, PhD, and Stavros Lomvardas, PhD, restored normal working memory in a mouse model of schizophrenia.
A gene that affects how mice encode fear memories could inform the study of PTSD in humans, according to a study led by Eric Kandel, MD.
A study led by Attila Losonczy, MD, PhD, shows how a type of brain cell affects navigation through our physical world as well as through our memories.
A new study led by Eric Kandel, MD, has identified a protein that could form the basis of a treatment for age-related memory loss.
Anthony Fitzpatrick, PhD, is among those turning the corner in the effort to understand, heal and improve the human brain.
Neuroscientists have discovered unexpected resilience in the brain.